Pharmacological blood pressure lowering in the older hypertensive patients may lead to cognitive impairment by altering neurovascular coupling

Medical Hypotheses

Volumn 80, Issue 3, 2013, Pages 303-307

  Alrawi, Yasir A ^a   Panerai, Ronney B ^b   Myint, Phyo Kyaw ^c,d   Potter, John F ^c,d  

^a JAMES PAGET UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; VALSARTAN;

AGING; ARTICLE; AUTOREGULATION; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PERFUSION; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE EXACERBATION; ELECTROENCEPHALOGRAM; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOTENSION; MENTAL PERFORMANCE; MULTIINFARCT DEMENTIA; NERVE CELL; NERVOUS SYSTEM PARAMETERS; NEUROVASCULAR COUPLING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REST; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; HUMANS; HYPERTENSION; MODELS, THEORETICAL;

EID: 84874545955     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.12.010     Document Type: Article

References (66)

1. Centers for Disease Control and Prevention (CDC) Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008. MMWR Morb Mortal Wkly Rep 2011, 60(4):103-108.
2. Health Survey for England 2009, Health and Lifestyles, vol. 1. NHS Information Centre.
3. Kalaria R.N., Maestre G.E., Arizaga R., Friedland R.P., Galasko D., Hall K., et al. World federation of neurology dementia research groupalzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 2008, 7(9):812-826.
4. Rait G., Fletcher A., Smeeth L., Brayne C., Stirling S., Nunes M., et al. Prevalence of cognitive impairment: results from the MRC trial of assessment and management of older people in the community. Age Ageing 2005, 34(3):242-248.
5. World Alzheimers Report 2010.
6. Cerhan J.R., Folsom A.R., Mortimer J.A., Shahar E., Knopman D.S., McGovern P.G., et al. Correlates of cognitive function in middle-aged adults. Atherosclerosis risk in communities (ARIC) study investigators. Gerontology 1998, 44(2):95-105.
7. Singh-Manoux A., Britton A.R., Marmot M. Vascular disease and cognitive function: evidence from the Whitehall II Study. J Am Geriatr Soc 2003, 51(10):1445-1450.
8. Elias M.F., Wolf P.A., D'Agostino R.B., Cobb J., White L.R. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 1993, 138(6):353-364.
9. Bowler J.V. Vascular cognitive impairment. J Neurol Neurosurg Psychiatry 2005, 76(Suppl. 5):v35-44.
10. Kalaria R.N. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000, 21(2):321-330.
11. Kokmen E., Whisnant J.P., O'Fallon W.M., Chu C.P., Beard C.M. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology 1996, 46(1):154-159.
12. Tatemichi T.K., Desmond D.W., Stern Y., Paik M., Sano M., Bagiella E. Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry 1994, 57(2):202-207.
13. Badan I., Dinca I., Buchhold B., Suofu Y., Walker L., Gratz M., et al. Accelerated accumulation of N- and C-terminal beta APP fragments and delayed recovery of microtubule-associated protein 1B expression following stroke in aged rats. Eur J Neurosci 2004, 19(8):2270-2280.
14. Nihashi T., Inao S., Kajita Y., Kawai T., Sugimoto T., Niwa M., et al. Expression and distribution of beta amyloid precursor protein and beta amyloid peptide in reactive astrocytes after transient middle cerebral artery occlusion. Acta Neurochir (Wien) 2001, 143(3):287-295.
15. Shi J., Yang S.H., Stubley L., Day A.L., Simpkins J.W. Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res 2000, 853(1):1-4.
16. Qiu C., Winblad B., Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005, 4(8):487-499.
17. Glynn R.J., Beckett L.A., Hebert L.E., Morris M.C., Scherr P.A., Evans D.A. Current and remote blood pressure and cognitive decline. JAMA 1999, 281(5):438-445.
18. Scherr P.A., Hebert L.E., Smith L.A., Evans D.A. Relation of blood pressure to cognitive function in the elderly. Am J Epidemiol 1991, 134(11):1303-1315.
19. Farmer M.E., White L.R., Abbott R.D., Kittner S.J., Kaplan E., Wolz M.M., et al. Blood pressure and cognitive performance. The Framingham Study. Am J Epidemiol 1987, 126(6):1103-1114.
20. Guo Z., Fratiglioni L., Zhu L., Fastbom J., Winblad B., Viitanen M. Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol 1999, 56(8):991-996.
21. Nilsson S.E., Read S., Berg S., Johansson B., Melander A., Lindblad U. Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older. Aging Clin Exp Res 2007, 19(1):41-47.
22. Hanon O., Pequignot R., Seux M.L., Lenoir H., Bune A., Rigaud A.S., et al. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints. J Hypertens 2006, 24(10):2101-2107.
23. Hanon O., Berrou J.P., Negre-Pages L., Goch J.H., Nádházi Z., Petrella R., et al. Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the observational study on cognitive function and systolic blood pressure reduction open-label study. J Hypertens 2008, 26(8):1642-1650.
24. Peila R., White L.R., Masaki K., Petrovitch H., Launer L.J. Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke 2006, 37(5):1165-1170.
25. Hajjar I., Catoe H., Sixta S., Boland R., Johnson D., Hirth V., et al. Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population. J Gerontol A Biol Sci Med Sci 2005, 60(1):67-73.
26. Fogari R., Mugellini A., Zoppi A., Derosa G., Pasotti C., Fogari E., et al. Influence of losartan and atenolol on memory function in very elderly hypertensive patients. J Hum Hypertens 2003, 17(11):781-785.
27. Forette F., Seux M.L., Staessen J.A., Thijs L., Babarskiene M.R., Babeanu S., et al. Systolic hypertension in europe investigators. The prevention of dementia with antihypertensive treatment: new evidence from the systolic hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002, 162(18):2046-2052.
28. Muldoon M.F., Waldstein S.R., Ryan C.M., Jennings J.R., Polefrone J.M., Shapiro A.P., et al. Effects of six anti-hypertensive medications on cognitive performance. J Hypertens 2002, 20(8):1643-1652.
29. Kalra L., Jackson S.H., Swift C.G. Psychomotor performance in elderly hypertensive patients. J Hum Hypertens 1993, 7(3):279-284.
30. Goldstein G., Materson B.J., Cushman W.C., Reda D.J., Freis E.D., Ramirez E.A., et al. Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a department of veterans affairs cooperative study. Hypertension 1990, 15(4):361-369.
31. Prince M.J., Bird A.S., Blizard R.A., Mann A.H. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the medical research council's trial of hypertension in older adults. BMJ 1996, 312(7034):801-805.
32. Birns J., Kalra L. Cognitive function and hypertension. J Hum Hypertens 2009, 23(2):86-96.
33. McGuinness B., Todd S., Passmore P., Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 2009, (4):CD004034.
34. Anderson C., Teo K., Gao P., Arima H., Dans A., Unger T., et al. ONTARGET and TRANSCEND investigators. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol 2011, 10(1):43-53.
35. Staessen J.A., Thijs L., Richart T., Odili A.N., Birkenhäger W.H. Placebo-controlled trials of blood pressure-lowering therapies for primary prevention of dementia. Hypertension 2011, 57(2):e6-7.
36. Chen H.S., Pellegrini J.W., Aggarwal S.K., Lei S.Z., Warach S., Jensen F.E., et al. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 1992, 12(11):4427-4436.
37. Paulson O.B., Strandgaard S., Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990, 2(2):161-192.
38. Eames P.J., Blake M.J., Dawson S.L., Panerai R.B., Potter J.F. Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2002, 72(4):467-472.
39. Dawson S.L., Blake M.J., Panerai R.B., Potter J.F. Dynamic but not static cerebral autoregulation is impaired in acute ischaemic stroke. Cerebrovasc Dis 2000, 10(2):126-132.
40. Krejza J., Mariak Z., Walecki J., Szydlik P., Lewko J., Ustymowicz A. Transcranial color doppler sonography of basal cerebral arteries in 182 healthy subjects: age and sex variability and normal reference values for blood flow parameters. AJR Am J Roentgenol 1999, 172(1):213-218.
41. Leenders K.L., Perani D., Lammertsma A.A., Heather J.D., Buckingham P., Healy M.J., et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 1990, 113(Pt 1):27-47.
42. Gur R.C., Gur R.E., Obrist W.D., Skolnick B.E., Reivich M. Age and regional cerebral blood flow at rest and during cognitive activity. Arch Gen Psychiatry 1987, 44(7):617-621.
43. Matsuda H., Maeda T., Yamada M., Gui L.X., Tonami N., Hisada K. Age-matched normal values and topographic maps for regional cerebral blood flow measurements by Xe-133 inhalation. Stroke 1984, 15(2):336-342.
44. Dai W., Lopez O.L., Carmichael O.T., Becker J.T., Kuller L.H., Gach H.M. Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. Stroke 2008, 39(2):349-354.
45. Beason-Held L.L., Moghekar A., Zonderman A.B., Kraut M.A., Resnick S.M. Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke 2007, 38(6):1766-1773.
46. Van Laere K., Dumont F., Koole M., Dierckx R. Non-invasive methods for absolute cerebral blood flow measurement using 99mTc-ECD: a study in healthy volunteers. Eur J Nucl Med 2001, 28(7):862-872.
47. Marchal G., Rioux P., Petit-Taboué M.C., Sette G., Travère J.M., Le Poec C., et al. Regional cerebral oxygen consumption, blood flow, and blood volume in healthy human aging. Arch Neurol 1992, 49(10):1013-1020.
48. Martin A.J., Friston K.J., Colebatch J.G., Frackowiak R.S. Decreases in regional cerebral blood flow with normal aging. J Cereb Blood Flow Metab 1991, 11(4):684-689.
49. Carey B.J., Eames P.J., Blake M.J., Panerai R.B., Potter J.F. Dynamic cerebral autoregulation is unaffected by aging. Stroke 2000, 31(12):2895-2900.
50. Serrador J.M., Sorond F.A., Vyas M., Gagnon M., Iloputaife I.D., Lipsitz L.A. Cerebral pressure-flow relations in hypertensive elderly humans: transfer gain in different frequency domains. J Appl Physiol 2005, 98(1):151-159.
51. Eames P.J., Blake M.J., Panerai R.B., Potter J.F. Cerebral autoregulation indices are unimpaired by hypertension in middle aged and older people. Am J Hypertens 2003, 16(9 Pt 1):746-753.
52. Traon A.P., Costes-Salon M.C., Galinier M., Fourcade J., Larrue V. Dynamics of cerebral blood flow autoregulation in hypertensive patients. J Neurol Sci 2002, 195(2):139-144.
53. Lipsitz L.A., Mukai S., Hamner J., Gagnon M., Babikian V. Dynamic regulation of middle cerebral artery blood flow velocity in aging and hypertension. Stroke 2000, 31(8):1897-1903.
54. Marstrand J.R., Garde E., Rostrup E., Ring P., Rosenbaum S., Mortensen E.L., et al. Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke 2002, 33(4):972-976.
55. Bellapart J., Fraser J.F. Transcranial Doppler assessment of cerebral autoregulation. Ultrasound Med Biol 2009, 35(6):883-893.
56. Aaslid R. Visually evoked dynamic blood flow response of the human cerebral circulation. Stroke 1987, 18:771-775.
57. Droste D.W., Harders A.G., Rastogi E. A transcranial doppler study of blood flow velocity in the middle cerebral arteries performed at rest and during mental activities. Stroke 1989, 20:1005-1011.
58. Jorgensen L., Perko G., Payne G., Secher N.H. Effect of limb anesthesia on middle cerebral response to handgrip. Am J Physiol Heart Circ Physiol 1993, 264:H553-H559.
59. Kelley R.E., Chang J.Y., Scheinman N.J., Levin B.E., Duncan R.C., Lee S.C. Transcranial doppler assessment of cerebral blood flow during cognitive tasks. Stroke 1992, 23:9-14.
60. Klingelhöfer J., Gernot M., Sander D., Scwarze J., Boecker H., Bischoff C. Assessment of functional hemispheric asymmetry by bilateral simultaneous cerebral blood flow velocity monitoring. J Cereb Blood Flow Metab 1997, 17:577-585.
61. Knecht S., Deppe M., Ebner A., Henningsen H., Huber T., Jokeit H., et al. Noninvasive determination of language lateralization by functional transcranial doppler sonography. Stroke 1998, 29:82-86.
62. Silvestrini M., Cupini L.M., Placidi F., Diomedi M., Bernardi G. Bilateral hemispheric activation in the early recovery of motor function after stroke. Stroke 1998, 29:1305-1310.
63. Stroobant N., Vingerhoets G. Transcranial doppler ultrasonography monitoring of cerebral hemodynamics during performance of cognitive tasks: a review. Neuropsychol Rev 2000, 10:213-231.
64. Tiecks F.P., Haberl R.L., Newell D.W. Temporal patterns of evoked cerebral blood flow during reading. J Cereb Blood Flow Metab 1998, 18:735-741.
65. Moody M., Panerai R.B., Eames P.J., Potter J.F. Cerebral and systemic hemodynamic changes during cognitive and motor activation paradigms. Am J Physiol Regul Integr Comp Physiol 2005, 288(6):R1581-8.
66. Panerai R.B., Moody M., Eames P.J., Potter J.F. Dynamic cerebral autoregulation during brain activation paradigms. Am J Physiol Heart Circ Physiol 2005, 289(3):H1202-8.